P
CIC
ContraceptionAtlas
CPIC
CPIC
CIC
Tracking access to modern contraception across Europe / February 2017
CIC
For more information, please visit Contraceptioninfo.eu
Expert Group
100%
95%
France
52.8%
Dr Petra De Sutter, Belgian Senate,
University of Ghent
COCs
United Kingdom
85%
COCs
Dr Tamar Khomasuridze, UNFPA
Belgium
80%
POPs
COCs
60.9%
POPs
70.5%
70%
Ms Ariella Rosansky, MSD
POPs
COCs
Norway
T
V
COCs
POPs
Austria
Ireland
Turkey
70.6%
65%
COCs
POPs
COCs
P
Luxembourg, Sweden
Slovenia Spain
Denmark Croatia
Malta, Romania
Switzerland
Serbia
Finland
Latvia, Kosovo
Iceland
Italy, Albania, FYROM
Czech Rep., Lithuania
Armenia, BiH
Montenegro
Belarus
Cyprus, Georgia
Slovakia
Hungary Poland
Ukraine
Azerbaijan
Estonia
POPs
P
60%
55%
59.1%
POPs
65%
87.6%
74%
United Kingdom
Netherlands
45%
83.5%
75.7%
Belgium
40%
60.9%
Bulgaria, Greece
Russia
35%
44.1%
90.1%
France
0
57.4%
Switzerland
52.2%
Italy
69.7%
Hungary
60.8%
48.6%
Montenegro
Male sterilization
(vasectomy)
T
V
97%
98%
Progestogen
only injectables
Lactational amenorrhea
method (LAM)
99%
97%
Monthly injectables
or combined injectable
contraceptives (CIC)
45.1%
2
Georgia
49.7%
39.9%
Azerbaijan
Armenia
2
88%
Combined contraceptive
patch and combined contraceptive vaginal ring (CVR)
38.2%
Standard Days Method
or SDM
99%
Bulgaria
Kosovo
Emergency contraception pills
(ulipristal acetate 30 mg
or levonorgestrel 1.5 mg)
95%
2
53.4%
>99%
Female sterilization
(tubal ligation)
2
57.9%
Herzegovina Serbia
>99%
2
50.8%
51.1% FYROM
Spain
97%
Moldova
58.8% 49.5%
Bosnia- 55.7%
59.7%
90%
99%
78.7%
Romania
Slovenia
Croatia
Portugal
CIC
>99%
99%
Ukraine
CIC
42.8%
Austria
99%
T
V
41.7%
CIC
Slovakia
66.5%
Female
condoms
Implants
T
P
CIC
Czech Republic
79%
99%
T
CPIC
50.7%
Luxembourg
48%
CIC
P
Germany
92%
Russia
P
Poland
Prof Medard Lech, European Society of
Contraception and Reproductive Health
Belarus
P
CIC
42.7%
V
T
V
T
Lithuania
CIC
POPs
P
CIC
T
37.5%
P
POPs
Ireland
50%
53.6%
Latvia
90%
Progestogen-only pills
(POPs) or “the minipill”
Prof Marleen Temmerman,
Aga Khan Development Network
V
T
50.1%
Denmark
Ms Ana Rizescu, YouAct
V
COCs
Netherlands
Estonia
Norway
Portugal
Hon. Marija Aušrinė Pavilionienė,
Lithuanian Parliament
V
Finland
Sweden
75%
V
55.2%
99%
Combined oral contraceptives
(COCs) or “the pill”
Dr Georgios Papadomanolakis,
Medecins du Monde (Greece)
COCs
Moldova
Germany
MODERN MEANS
OF CONTRACEPTION
Dr Jacques De Haller, Standing
Committee of European Doctors (CPME)
Iceland
90%
75%
2
Albania
38.2%
2
64.3%
Intrauterine device (IUD):
50 containing
copper
Turkey
Greece
54.9
2
Basal Body
Temperature (BBT) Method
96%
>99%
86%
2
V
58%
Malta
T
T
Innovation Centre for the visualization
of the findings. EPF is grateful to the numerous
expert national organisations and individuals
who contributed to gathering the data presented
Sympto-thermal
Method
Superior to other
No reimbursement
No reimbursement
No reimbursement
No reimbursement
Similar to other
No reimbursement
No reimbursement
Similar to other
No reimbursement
No reimbursement
No reimbursement
Less than other
No reimbursement
Similar to other
No reimbursement
No reimbursement
No reimbursement
No reimbursement
No reimbursement
No reimbursement
Less than other
No reimbursement
No reimbursement
No reimbursement
No reimbursement
No reimbursement
No reimbursement
No reimbursement
No reimbursement
Less than other
No reimbursement
No reimbursement
Similar to other
No reimbursement
No reimbursement
No reimbursement
No reimbursement
Similar to other
Less than other
No reimbursement
No reimbursement
Less than other
No reimbursement
Similar to other
Yes
No
No
No
No
Yes
No
No
No
No
No
No
Yes
No
Yes
No
No
Yes
No
No
No
No
No
No
No
No
Yes
No
Yes
No
Yes
Yes
No
No
No
No
No
No
No
No
Yes
No
No
No
Yes
Yes
Yes
No
No
Yes
Yes
No
No
No
No
No
Yes
No
No
Yes
No
No
No
No
No
No
Yes
No
No
No
No
No
Yes
Yes
No
No
No
No
Yes
No
No
No
No
No
No
No
No
No
No
Yes
Superior to other
Similar to other
Similar to other
Similar to other
Similar to other
Superior to other
Less than other
No reimbursement
Similar to other
Similar to other
Similar to other
Superior to other
Similar to other
Superior to other
Superior to other
No reimbursement
Less than other
Superior to other
Similar to other
Similar to other
Similar to other
No reimbursement
Superior to other
Similar to other
Similar to other
Similar to other
Superior to other
Similar to other
Superior to other
No reimbursement
Similar to other
Similar to other
Similar to other
Superior to other
Superior to other
Similar to other
Similar to other
Similar to other
Similar to other
Similar to other
Similar to other
Superior to other
Similar to other
Similar to other
Similar to other
No
Yes (direct consent)
No
No
No
No
No
Yes (indirect consent)
No
No
No
No
No
No
No
No
No
No
Yes (indirect consent)
No
No
No
No
No
No
Yes (indirect consent)
No
No
No
No
No
No
Yes (direct consent)
No
No
No
No
Yes (direct consent)
No
No
No
No
No
Yes (direct consent)
No
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Availability of self-administered
hormonal contraception
without prescription
77.7%
58.7%
49.8%
60.3%
58.9%
74.5%
51.9%
36.9%
73,6%
49,8%
49.8%
61.2%
67.9%
52.1%
84.8%
53.7%
47.1%
62.4%
48.5%
38%
49.8%
60.1%
52.1%
60.3%
49.8%
43.6%
62.4%
58.9%
82%
53.7%
67.9%
60%
39.1%
74.5%
52.1%
42.9%
54.7%
39.1%
63.1%
57.7%
60%
52.1%
57.7%
44%
82.4%
Availability
of Emergency Contraception
Not avalaible
Insufficient
Exceptional
Not avalaible
Good
Exceptional
Good
Insufficient
Insufficient
Insufficient
Exceptional
Good
Exceptional
Exceptional
Exceptional
Good
Exceptional
Exceptional
Insufficient
Good
Exceptional
Exceptional
Exceptional
Insufficient
Exceptional
Good
Exceptional
Exceptional
Good
Insufficient
Good
Exceptional
Exceptional
Exceptional
Exceptional
Insufficient
Good
Exceptional
Exceptional
Exceptional
Exceptional
Good
Good
Good
Exceptional
PRESCRIPTION REQUIREMENTS
Legal Status (marital, citizenship)
Is Not a Barrier
Not avalaible
Insufficient
Exceptional
Not avalaible
Good
2Exceptional
Good
2
Insufficient
Insufficient
2
Good
Good
Good
2
Exceptional
2Exceptional
Exceptional
2
Insufficient
Insufficient
2
Exceptional
2Insufficient
2Exceptional
Good
Exceptional
Good
Insufficient
Insufficient
Exceptional
Good
Exceptional
Good
Insufficient
Exceptional
Good
Good
Exceptional
Exceptional
Insufficient
Exceptional
Exceptional
Good
Exceptional
Good
Good
Exceptional
Good
Exceptional
T
Special Reimbursement for Vulnerable
Groups (unemployed, low-income)
No
Yes
Yes
No
No
Yes
No
No
No
No
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
No
Yes
No
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
No
No
No
Yes
No
Yes
Yes
No
Yes
Yes
T
COUNSELLING
Special Reimbursement
for Adolescents (until 19)
Not avalaible
Good
Exceptional
Not avalaible
Insufficient
Exceptional
Insufficient
Insufficient
Insufficient
Good
Insufficient
Insufficient
Exceptional
Insufficient
Exceptional
Insufficient
Not avalaible
Exceptional
Insufficient
Good
Insufficient
Exceptional
Insufficient
Insufficient
Good
Exceptional
Insufficient
Insufficient
Exceptional
Insufficient
Exceptional
Good
Good
Insufficient
Exceptional
Insufficient
Good
Insufficient
Good
Good
Good
Exceptional
Exceptional
Insufficient
Exceptional
Level of Reimbursement
Logistical Information
Not avalaible
Insufficient
Exceptional
Not avalaible
Not avalaible
Exceptional
Insufficient
Insufficient
Insufficient
Insufficient
Insufficient
Insufficient
Insufficient
Insufficient
Exceptional
Insufficient
Not avalaible
Exceptional
Not avalaible
Insufficient
Insufficient
Insufficient
Insufficient
Insufficient
Insufficient
Good
Insufficient
Not avalaible
Good
Insufficient
Exceptional
Exceptional
Insufficient
Insufficient
Insufficient
Insufficient
Insufficient
Insufficient
Insufficient
Insufficient
Insufficient
Insufficient
Good
Insufficient
Exceptional
ACCESS TO SUPPLIES & COUNSELLING
Financial Information
Not avalaible
Insufficient
Superior
Not avalaible
Weak
Superior
Standard
Standard
Insufficient
Weak
Standard
Superior
Superior
Superior
Superior
Standard
Superior
Superior
Insufficient
Standard
Superior
Superior
Standard
Standard
Superior
Weak
Superior
Superior
Superior
Standard
Standard
Superior
Weak
Superior
Superior
Insufficient
Superior
Standard
Standard
Superior
Superior
Superior
Superior
Insufficient
Superior
Ease of Finding the Website
Number of Contraceptives
Other online resources
Other online resources
Gov't supported integrated website
Other online resources
Non-gov't supported websites
Gov't supported standalone website
Non-gov't supported websites
Gov't supported integrated website
Gov't supported integrated website
Non-gov't supported websites
Non-gov't supported websites
Gov't supported integrated website
Gov't supported standalone website
Non-gov't supported websites
Gov't supported standalone website
Gov't supported integrated website
Other online resources
Gov't supported standalone website
Other online resources
Non-gov't supported websites
Non-gov't supported websites
Gov't supported standalone website
Non-gov't supported websites
Gov't supported integrated website
Non-gov't supported websites
Non-gov't supported websites
Non-gov't supported websites
Gov't supported standalone website
Non-gov't supported websites
Non-gov't supported websites
Gov't supported integrated website
Gov't supported integrated website
Non-gov't supported websites
Non-gov't supported websites
Non-gov't supported websites
Other online resources
Non-gov't supported websites
Non-gov't supported websites
Non-gov't supported websites
Non-gov't supported websites
Non-gov't supported websites
Gov't supported standalone website
Gov't supported integrated website
Non-gov't supported websites
Gov't supported integrated website
Visualization or Ease of Navigation
Type of Online Information
2.5%
33.3%
97.1%
2.5%
28%
100%
44.9%
40.7%
31.7%
37.1%
52.3%
55.1%
75.5%
60.7%
100%
45.6%
41.5%
100%
19.4%
51.5%
58.3%
74%
52.3%
40.7%
60.5%
62.1%
58.3%
56.6%
72.8%
39.5%
85.2%
89.7%
49.4%
60.7%
68,4%
27.6%
57.5%
53.2%
56.5%
63.4%
62.5%
67.2%
76.4%
37.5%
97.1%
Minority Languages in the Same
Website (if relevant)
AVAILABILITY OF ONLINE INFORMATION
51.1%
49.7%
66.5%
39.9%
48%
83.5%
49.5%
38.2%
58.8%
45.3%
50.7%
59.1%
70.6%
55.2%
90.1%
50.8%
45.1%
75.7%
38.2%
42.8%
52.8%
65%
52.2%
53.4%
53.6%
50.1%
60.9%
58%
78.7%
48.6%
74%
70.5%
42.7%
69.7%
57.9%
37.5%
55.7%
44.1%
60.8%
59.7%
60.9%
57.4%
64.3%
41.7%
87.6%
T
85%
Male
condoms
Need for Third-Party Consent
REIMBURSEMENT
T
V
*Belgium, Germany and Spain have federal political systems and therefore circumstances may vary between regions. **Under UNSCR 1244/99
98%
ACCESS TO SUPPLIES & COUNSELLING
T
USER FRIENDLINESS
V
V
T
100
in the Atlas. The scope and content of the European
Contraception Atlas is the sole responsibility
of the European Parliamentary Forum
on Population & Development (EPF).
V
TYPE OF ONLINE INFORMATION
TwoDay
Method
98%
rights who designed the questions and structures.
V
T
EPF benefitted from the financial support
of MSD
to undertake original and independent research
which is presented in the Atlas and Vthe MSD Global
AVAILABILITY OF ONLINE INFORMATION
Albania
Armenia
Austria
Azerbaijan
Belarus
Belgium*
Bosnia-Herzegovina
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
FYROM
Georgia
Germany*
Greece
Hungary
Iceland
Ireland
Italy
Kosovo**
Latvia
Lithuania
Luxembourg
Malta
Moldova
Montenegro
Netherlands
Norway
Poland
Portugal
Romania
Russia
Serbia
Slovakia
Slovenia
Spain*
Sweden
Switzerland
Turkey
Ukraine
United Kingdom
74.9
Level of available, accessible,
and affordable consultation
This initiative is powered by the European
Parliamentary Forum on Population & Development
(EPF) with the support of Third-I and group of
experts in sexual and reproductive health and
45.3%
V
Who is behind the Atlas?
FOR EDUCATION,
EMPOWERMENT
& EQUALITY
59.9
Intrauterine
device (IUD)
levonorgestrel
Cyprus
V
ACCESS TO MODERN CONTRACEPTION
The below group of experts in sexual
and reproductive health and rights
designed the questions and structures
for the Contraception Atlas.
Yes (presc. required)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (presc. required)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (presc. required)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
Yes (without presc.)
No
Yes
No
Yes
No
No
Yes
No
Yes
No
No
No
No
No
No
Yes
No
No
Yes
No
No
No
No
Yes
No
No
No
No
Yes
Yes
No
No
No
No
No
Yes
Yes
No
No
No
No
No
Yes
Yes
No
Albania
Armenia
Austria
Azerbaijan
Belarus
Belgium*
Bosnia-Herzegovina
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
FYROM
Georgia
Germany*
Greece
Hungary
Iceland
Ireland
Italy
Kosovo**
Latvia
Lithuania
Luxembourg
Malta
Moldova
Montenegro
Netherlands
Norway
Poland
Portugal
Romania
Russia
Serbia
Slovakia
Slovenia
Spain*
Sweden
Switzerland
Turkey
Ukraine
United Kingdom